Mineur YS, Cahuzac EL, Mose TN, Bentham MP, Plantenga ME, Thompson DC, et al
For T2DM patients at high-risk or established cardiovascular disease, heart failure and/or chronic kidney disease, glucose-lowering therapies with demonstrated cardiorenal benefit should be utilized where appropriate
Discussion Asthma is a heterogeneous disorder that is causally classified into Type-2 asthma and non-Type-2 asthma based on pathological and immunological features [32, 33]
If this affects you, try injecting in the morning rather than the evening
Call the Metabolic Medical Center location closest to you or request an appointment online
Mapping synthetic binding proteins epitopes on diverse protein targets by protein structure prediction and protein-protein docking